364
W. Liu, C. Tao, L. Tang, J. Li, Y. Jin, Y. Zhao, and H. Hu
Vol 48
C, 58.50; H, 4.42; N, 11.26. MS (EI): m/z 394 [(M-HBr-H2O)þ,
2.9], 219 (92), 218 (100), 192 (2.2), 176 (96.6), 134 (56.6).
N-(4-phenyl-thiazol-2-yl)-2-formylfuran hydrazone (4b). Brown-
ish yellow crystals, yield 87%, m.p. 136–138ꢁC; IR (KBr):
REFERENCES AND NOTES
[1] (a) Karki, S. S.; Thota, S.; Darj, S. Y.; Balzarini, J.; Clercq,
E. D. Bioorg Med Chem 2007, 15, 6632; (b) Gojo, I.; Tidwell, M. L.;
Greer, J.; Takebe, N.; Seiter, K.; Pochron, M. F.; Johnson, B.; Sznol,
M.; Karp, J. E. Leukemia Res 2007, 31, 1165.
3117, 3141, 3065, 1619, 1603, 1561, 1486, 760, 691 cmꢀ1
;
1H-NMR (300 MHz, DMSO-d6): d 6.59–6.62 (m, 1H, furan-2-
yl C4AH), 6.81 (d, J ¼ 3.3 Hz, 1H, furan-2-yl C3AH), 7.23–
7.93 (m, 9H, thiazole ring and phenyl proton, furan-2-yl
C5AH, ¼¼CAH, ANHA). Anal. Calcd for C14H11N3OS: C,
62.45; H, 4.09; N,15.61. Found: C, 62.53; H, 4.05; N,15.77.
MS (EI): m/z 269 (Mþ, 16.8), 176 (100), 134 (62.6).
[2] Wiles, D. M.; Suprunchuk, T. J Med Chem 1971, 14, 252.
[3] Gupta, M. K.; Sachan, A. K.; Pandeya, S. N. Asian J Chem
2007, 19, 5.
[4] Klayman, D. L.; Lin, A. J.; Hoch, J. M.; Scovill, J. P.;
Lambros, C.; Dobek, A. S. J Pharm Sci 1984, 73, 1763.
[5] Klayman, D. L.; Lin, A. J.; McCall, J. W.; Wang, S. Y.;
Townson, S.; Grogl, M.; Kinnamon, K. E. J Med Chem 1991, 34,
1422.
N-(4-phenyl-thiazol-2-yl)-2-formylthiophene hydrazone (4c).
Light brown crystals, yield 66%, m.p. 202–203ꢁC; IR (KBr):
3302, 3099, 3055, 1602, 1561, 1521, 1505, 1490, 768, 748,
[6] Kizilcikli, I.; Kurt, Y. D.; Akkurt, B.; Genel, A. Y.; Birtek-
1
740, 722, 706, 683 cmꢀ1; H-NMR (300 MHz, CDCl3): d 6.80
¨
¨
¨
¨
¨
soz, S.; Otuk, G.; Ulkuseven, B. Folia Microbiol 2007, 52, 15.
[7] (a) Liu, W. W.; Zhao, Y. Q.; Pu, Y. Q.; Xu, R. B.; Hu, H.
W. Chin J Org Chem 2005, 25, 838; (b) Liu, W. W.; Zhao, Y. Q.;
Xu, R. B.; Tang, L. J.; Hu, H. W. Chin J Chem 2006, 24, 1472; (c)
Liu, W. W.; Tang, L. J.; Zeng, Y. X.; Wang, L.; Zhao, Y. Q.; Chen,
K. Q.; Lu, Z. E. Chin J Org Chem 2007, 27, 1285; (d) Liu, W. W.;
Tu, S. J.; He, T.; Zhao, Y. Q.; Hu, H. W. J Heterocyclic Chem 2008,
45, 1311.
(s, 1H, thiazole ring proton), 7.00–7.90 (m, 8H, thiophen-2-yl
and phenyl proton), 7.97 (s, 1H, ACH¼¼NA), 8.20 (br, s, 1H,
ANHA). Anal. Calcd for C14H11N3S2: C, 58.95; H, 3.86; N,
14.74.Found: C, 59.01; H, 3.96; N, 14.65. MS (EI): m/z 285
(Mþ, 15.8), 176 (100), 134 (83.5), 110 (4.4), 77 (2.5).
N-(4-phenyl-thiazol-2-yl)-2-formyl-1H-indole hydrazone (4d).
Light purple crystals, yield 90%, m.p. 185–187ꢁC; IR (KBr):
3292, 3103, 2943, 1625, 1608, 1574, 1531, 1491, 749, 735
675 cmꢀ1 1H-NMR (300 MHz, DMSO-d6): d 7.15–7.52 (m,
;
8H, thiazole ring and phenyl proton, indol-3-yl C6AH, indol-3-
yl C7AH), 7.78 (s, 1H, ANHA), 7.85–7.95 (m, 2H, indol-3-yl
C8AH, indol-3-yl C2AH), 8.23–8.35 (m, 2H, indol-3-yl C5AH,
¼¼CHA), 11.61 (s, 1H, indol-3-yl nitrogen proton). Anal. Calcd
for C18H14N4S: C, 67.92; H, 4.40; N, 17.61. Found: C, 67.93;
H, 4.32; N, 17.66. MS (EI): m/z 318 (Mþ, 0.5), 176 (100), 142
(59.6), 134 (38.4), 115 (7.4), 89 (5.2).
[8] (a) Anderson, F. E.; Duca, C. J.; Scudi, J. V. J Am
Chem Soc 1951, 73, 4967; (b) Bernstein, J.; Yale, H. L.; Losee,
K.; Holsing, M.; Martins, J.; Lott, W. A. J Am Chem Soc 1951,
73, 906.
[9] Crystal data for 2a: 2(C16H14N4S)ꢂC2H6CO; M ¼ 646, Yel-
low single crystals, 0.20 ꢃ 0.20 ꢃ 0.30 mm3, triclinic, space group
˚
P1, a ¼ 11.572 (8), b ¼ 11.845 (8), c ¼ 13.173 (8) A, a ¼ 92.56 (3),
3
ꢁ
˚
b ¼ 110.61 (4), c ¼ 102.57 (4) , V ¼ 1635 (2) A , Z ¼ 2, Dc
¼
1.318 mg mꢀ3. F (000) ¼ 682, l (MoKa) ¼ 0.206 mmꢀ1. Intensity
data were collected on Bruker SMART APEX II with graphite mono-
˚
N-(4-phenyl-thiazol-2-yl)-x-(1, 2, 4-triazol-1-yl)acetophe-
none hydrazone (4e) Light yellow crystals, yield 61%, m.p.
212–214ꢁC; IR (KBr): 3165, 3096, 3081, 2656, 1598, 1583,
chromated MoKa radiation (k ¼ 0.71073 A) using x scan mode with
1.9ꢁ < y < 25.0ꢁ. 5671 unique reflections were measured and 4302
reflections with I > 2r(I) were used in the refinement. Structure
solved by direct methods and expanded using Fourier techniques. The
final cycle of full-matrix least squares technique to R ¼ 0.0533 and
wR ¼ 0.1168.
1
1503, 1444, 749, 688 cmꢀ1; H-NMR (300 MHz, DMSO-d6):
d 5.74 (s, 2H, ACH2A); 7.33–7.89 (m, 11H, thiazole ring and
phenyl proton), 7.97 (s, 1H, 1H-1, 2, 4-triazol-1-yl proton),
8.74 (s, 1H, 1H-1, 2, 4-triazol-1-yl proton). Anal. Calcd for
C19H16N6S: C, 58.95; H, 3.86; N, 14.74. Found: C, 59.01; H,
3.96; N, 14.65. MS (EI): m/z 291 (22.7), 262 (18.8), 176 (9.4),
134 (59.9), 103 (100), 77 (66.5), 69 (13.9).
[10] Crystal data for 3a: C24H21BrN4OS; M ¼ 493, Blackish
green single crystals, 0.42 ꢃ 0.36 ꢃ 0.20 mm3, monoclinic, space
˚
group P21/n, a ¼ 6.1679 (12), b ¼ 11.1657 (18), c ¼ 32.640 (4) A, a
3
ꢁ
˚
¼ 90, b ¼ 91.708 (2), c ¼ 90 , V ¼ 2246.9 (6) A , Z ¼ 4, Dx
¼
1.459 mg mꢀ3. F (000) ¼ 1008, l (MoKa) ¼ 1.946 mmꢀ1. Intensity
Acknowledgments. The authors are grateful to the National
Natural Science Foundation of China (No. 20672090), the Six
Kinds of Professional Elite Foundation of Jiangsu Province
(No. 07-A-024), the Science and Technology Critical Project
Foundation of Lianyungang Municipality (CG0803-2), and the
Natural Science Foundation of Jiangsu Education Department
(08KJB150002).
data were collected on Bruker SMART APEX II with graphite mono-
˚
chromated MoKa radiation (k ¼ 0.71073 A) using x scan mode with.
1.93ꢁ < y < 25.01ꢁ. 3904 unique reflections were measured and 2795
reflections with I > 2r(I) were used in the refinement. Structure
solved by direct methods and expanded using Fourier techniques. The
final cycle of full-matrix least squares technique to R ¼ 0.0661 and
wR ¼ 0.1554.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet